Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LX

Li Xing — 29 Patents

Pfizer: 18 patents #185 of 5,153Top 4%
APAcurx Pharmaceuticals: 3 patents #8 of 22Top 40%
PHPharmacia: 2 patents #645 of 1,582Top 45%
ETEnsemble Therapeutics: 1 patents #7 of 28Top 25%
NCNeurotech Pharmaceuticals Co.: 1 patents #16 of 28Top 60%
Overall (All Time): #127,851 of 4,157,543Top 4%
29 Patents All Time
Li Xing has been granted 29 US patents while listed as an inventor at Pfizer. The first was granted in 2006 and the most recent in December 2025. Li Xing ranks #127,851 of 4,157,543 US inventors in our database (top 3.1%). Patent records list Li Xing in Shanghai, MA, CN.

Issued Patents All Time

Showing 1–25 of 29 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12509447 Small molecule compound Guanqun Li, Xinyu Wang, Yufeng Cai, Xiang Jiang, Xianfeng Pan +3 more 2025-12-30
12384795 Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereof Ao Zhang, Jian Ding, Hua Xie, Zilan Song, Yu-Yi Xue +2 more 2025-08-12
12129256 Pyrazolo[1,5-a]pyrazin-4-yl derivatives Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more 2024-10-29 $505,385,000
11834432 Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof Ao Zhang, Meiyu Geng, Jing Ai, Zilan Song, Xia Peng +2 more 2023-12-05
11472809 Pyrazolo[1,5-a]pyrazin-4-yl derivatives Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more 2022-10-18 $393,425,000
11254668 Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives Brian Stephen Gerstenberger, Andrew Fensome, Dafydd Rhys Owen, Matthew Frank Brown, Matthew Merrill Hayward +2 more 2022-02-22 $482,573,000
11197867 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Brian Stephen Gerstenberger, Ivan Viktorovich Efremov, Zhao-Kui Wan +5 more 2021-12-14 $1,320,244,000
11001592 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Minghua Wang, Casey Cameron McComas, Michael SILVERMAN, Richard Soll 2021-05-11
10980815 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Brian Stephen Gerstenberger, Ivan Viktorovich Efremov, Zhao-Kui Wan +5 more 2021-04-20 $674,734,000
10836772 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Minghua Wang, Casey Cameron McComas, Michael SILVERMAN, Richard Soll 2020-11-17
10822341 Pyrazolo[1,5-a]pyrazin-4-yl derivatives Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more 2020-11-03 $385,583,000
10815213 Bruton's tyrosine kinase inhibitors John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more 2020-10-27 $309,700,000
10723741 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Minghua Wang, Casey Cameron McComas, Michael SILVERMAN, Richard Soll 2020-07-28
10493129 Use of fibroblast growth factor 2 Xiliang Wang, Chengyu JIANG, Penghui Yang, Xin Liu, Yueqiang Duan +1 more 2019-12-03
10463675 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Brian Stephen Gerstenberger, Ivan Viktorovich Efremov, Zhao-Kui Wan +5 more 2019-11-05 $427,991,000
10426135 Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more 2019-10-01 $298,967,000
10385036 Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more 2019-08-20 $837,148,000
10336748 Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more 2019-07-02 $980,917,000
10308615 Heterocyclic compounds as inhibitors of Vanin-1 enzyme Agustin Casimiro-Garcia, Jeffrey Scott Condon, Andrew Christopher Flick, Ariamala Gopalsamy, Steven J. Kirincich +4 more 2019-06-04 $869,926,000
10266513 Bruton's tyrosine kinase inhibitors John Robert Springer, Balekudru Devadas, Danny James Garland, Margaret L. Grapperhaus, Seungil Han +9 more 2019-04-23 $877,937,000
10227346 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +6 more 2019-03-12 $419,848,000
10144738 Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives Matthew Frank Brown, Alpay Dermenci, Andrew Fensome, Brian Stephen Gerstenberger, Matthew Merrill Hayward +3 more 2018-12-04 $489,814,000
9670201 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Andrew Christopher Flick, Peter Jones, Neelu Kaila, Scot Richard Mente +5 more 2017-06-06 $303,831,000
9663526 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Brian Stephen Gerstenberger, Ivan Viktorovich Efremov, Zhao-Kui Wan +5 more 2017-05-30 $667,472,000
9284283 Macrocyclic compounds for modulating IL-17 Michael D. Taylor, Nicholas K. Terrett, William H. Connors, Cheri Snedeker, Kelley C. Shortsleeves +8 more 2016-03-15